|
Volumn 16, Issue 11, 2008, Pages 6218-6232
|
Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity
|
Author keywords
2,3 Oxidosqualene:lanosterol cyclase; Hypercholesterolemia; OSC inhibitor; Pharmacophore
|
Indexed keywords
1 (4 CHLOROPHENYLCARBONYL) 4 [4 (IMIDAZOL 1 YL)PHENYLMETHYL]PIPERAZINE;
1 (4 CHLOROPHENYLSULFONYL) 4 [4 (4 METHYLPIPERAZIN 1 YL)PHENYLMETHYL]PIPERAZINE;
3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE;
BIBB 515;
ENZYME INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LANOSTEROL SYNTHASE;
LANOSTEROL SYNTHASE INHIBITOR;
RO48 8071;
ZD 9720;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CATARACT;
CHOLESTEROL SYNTHESIS;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG DESIGN;
DRUG LIVER LEVEL;
EYE TOXICITY;
FEMALE;
HUMAN;
HUMAN CELL;
MALE;
NONHUMAN;
PHARMACOPHORE;
RAT;
SINGLE DRUG DOSE;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
CATARACT;
CELL LINE, TUMOR;
DYSLIPIDEMIAS;
ENZYME INHIBITORS;
EYE;
FEMALE;
HUMANS;
INTRAMOLECULAR TRANSFERASES;
LIVER;
MALE;
OXAZOLES;
PIPERAZINES;
PIPERIDINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RATTUS;
|
EID: 44449115634
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2008.04.034 Document Type: Article |
Times cited : (16)
|
References (25)
|